Skip to content
★ Sign in to follow
Centenial Surgical logo

Centenial Surgical Stock: price and insider trades · India

IN·Mcap ₹259.9M

Centenial Surgical: what insiders have been doing

Centenial Surgical is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). In the past year (8 November 2025 to 8 November 2026), 3 filings came from 3 insiders.

Only sales appear on the open market, 3 sales in all totalling €953, filed by 3 insiders. Biggest ticket of the year: €563, sold by Vipul Navinchandra Shah HUF and made public on 2 July 2026 (0.016% of market cap).

The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

For context, the typical company on the same exchange (median of 1,985 companies) published 4 filings over the same period, against 3 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 3 sales.

Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€953
3 ops. · all time

Who traded when

BuySale
Ruchit Vipul Shah1 sale
Sonal Vipulbhai Shah1 sale
Vipul Navinchandra Shah HUF1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,808 of 26,912 companies
41.0
score / 100
Value
49
Quality
33
FCF yld19%
Earn yld-8.5%
EV/EBITDA13.5x
ROE-7.4%
Gross mgn65%
Net mgn-4.1%
Debt/EBITDA7.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹71.25
Analyst consensus
·
Income statement
Revenue₹538.4M
Gross profit₹350.9M65% margin
EBITDA₹52.6M10% margin
Net income-₹22M-2.5% margin
Valuation
P/Book0.9x
Beta0.20
Balance sheet & cash
Market cap₹259.9M
Total debt₹107.1M
Free Cash Flow₹50.5M
Debt / Equity106%
Profitability & ownership
ROE-7.4%
ROA0.8%
% insiders82.1%
% institutions0.0%
Last declaration on 2 July 2026
Declarations3 total
  • ▼
    Related company / holdingExecutives
    61,556 INR20SEBI
    801 shares@ ₹76.800.016% mcap100.0% of flowEquityMarket SaleSEBI:050ba57af80d2769f645504558aee8af7c082522
  • ▼
    Directors Immediate RelativeExecutives
    769 INR20SEBI
    10 shares@ ₹76.900.0002% mcap100.0% of flowEquityMarket SaleSEBI:b11e158cf042bad608b1efad7b853b22faae5e6c
  • ▼
    Directors Immediate RelativeExecutives
    41,915 INR20SEBI
    505 shares@ ₹83.000.011% mcap100.0% of flowEquityMarket SaleSEBI:419f31d8219e0ffc53562a47ac38ce52a24366f4

3 of 3 declarations

About Centenial Surgical

Centenial Surgical is a company focused on developing innovative medical devices. It operates in the XBOM market, providing solutions to enhance surgical procedures.